Which is better, targeted therapy or endocrine therapy for breast cancer

Breast cancer refers to a malignant lesion caused by the uncontrolled proliferation of breast epithelial cells under the influence of multiple carcinogenic factors. Targeted therapy and endocrine therapy are both methods used to treat breast cancer. It is impossible to simply judge which one is more effective. Patients should choose a treatment plan that suits them under the guidance of a doctor. The specific analysis is as follows:

1. Targeted therapy: Targeted therapy for breast cancer mainly combines physical conditions and uses anti-cancer drugs according to doctor's orders. While killing cancer cells, it can also avoid damaging normal cells in the human body, causing less burden on the body and less side effects. This method of treatment can also interfere with the reproduction of cancer cells by changing or inhibiting the biochemical metabolism of cancer cells. The more commonly used drugs are abemaciclib tablets, trastuzumab injection, and pertuzumab injection.

2. Endocrine therapy: Endocrine therapy for breast cancer mainly uses drugs or removes endocrine glands, which can regulate the endocrine function in the body, reduce the secretion of endocrine hormones, reduce the recurrence rate of breast cancer after surgery, and improve the quality of life of patients. The more commonly used drugs are tamoxifen citrate tablets, triptorelin acetate injection, leuprorelin acetate microspheres for injection, etc.

Since breast cancer varies from patient to patient, such as physical condition and severity of the disease, it is impossible to simply judge whether targeted therapy or endocrine therapy is better. It is recommended that patients go to the hospital for medical treatment, complete relevant examinations, and then choose the appropriate treatment method under the guidance of a doctor based on their physical condition.